RUA Life Sciences (LON:RUA) Issues Earnings Results

RUA Life Sciences (LON:RUA) issued its quarterly earnings results on Friday. The company reported GBX (0.23) EPS for the quarter, Digital Look Earnings reports. RUA Life Sciences had a negative return on equity of 26.38% and a negative net margin of 65.72%.

RUA Life Sciences Price Performance

Shares of RUA stock traded down GBX 1.17 on Friday, hitting GBX 14.58. 678,323 shares of the company’s stock were exchanged, compared to its average volume of 266,941. The stock has a market cap of £9.05 million, a P/E ratio of -2.61 and a beta of 1.21. The company has a debt-to-equity ratio of 5.42, a current ratio of 9.01 and a quick ratio of 7.32. RUA Life Sciences has a 12 month low of GBX 10.42 and a 12 month high of GBX 16.80. The company has a 50 day moving average of GBX 13.06 and a 200 day moving average of GBX 12.02.

RUA Life Sciences Company Profile

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.